Lixte Biotechnology Holdings- Warrants (01/01/2025) Net Tangible Assets

As of the most recent data (June 2026), LIXTW shows a net tangible assets of $25M. That compares with $650K in the prior-year period — up 3735.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LIXTW's net tangible assets is now $25M (was $650K) — a 3735.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Lixte Biotechnology Holdings- Warrants (01/01/2025) is outperforming or lagging.

Tracking LIXTW's net tangible assets over time shows whether Lixte Biotechnology Holdings- Warrants (01/01/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $25M That compares with $650K in the prior-year period — up 3735.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Lixte Biotechnology Holdings- Warrants (01/01/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $25M) with ownership activity and broader fundamentals.

Lixte Biotechnology Holdings- Warrants (01/01/2025)'s net tangible assets is $25M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.